The UK government has announced a £9 million investment to enhance treatment for individuals with sickle cell disease, primarily affecting people from African-Caribbean backgrounds. This funding aims to improve apheresis services across England by establishing more specialized treatment centers and expanding access to Spectra Optia technology. This innovative treatment reduces complications associated with sickle cell disease and promises considerable cost savings for the NHS by minimizing hospital stays. Health secretary Wes Streeting emphasized the importance of leveraging new technologies to provide better healthcare access for patients with rare conditions.
People living with rare conditions like sickle cell disease face immense everyday challenges, and can sometimes struggle to get the specialized care they need.
Through our plan for change, this government will be the one that removes the barriers to getting the latest and best tech to our NHS frontline.
Collection
[
|
...
]